How much funding has Attovia raised?

Attovia has raised $255.0M in total funding, most recently a Series C round.

Who are Attovia's investors?

Attovia's investors include Frazier Life Sciences, Deep Track Capital, Goldman Sachs Alternatives, venBIO Partners, Illumina Ventures, Vida Ventures.

Where is Attovia headquartered?

Attovia is headquartered in Fremont, California, United States.

What industry is Attovia in?

Attovia operates in Biotech, Healthcare.

Attovia

Shaping the future of I&I with first-in-class multispecifics

Fremont, United States · Founded 2023 · $255.0M raised

Biotech

Healthcare

Headquarters: Fremont, California
Founded: 2023
Business Model: B2B
Website: attovia.com

Total Funding: $255.0M
Last Round: $90.0M Series CApr 2025
Rounds: 3

About

Attovia Therapeutics is a clinical-stage biopharmaceutical company creating a pipeline of biotherapeutics with an initial focus on immune-mediated diseases and oncology. Founded in 2023, the company leverages its proprietary ATTOBODY™ platform — a biparatopic nanobody technology — to develop first-in-class precision biologics designed to address areas of high unmet medical need. Attovia has raised Series A, B, and C financing to advance its pipeline toward the clinic.

Summary

Attovia is a Biotech company based in Fremont, United States, founded in 2023. It has raised $255.0M in total across 3 rounds, most recently a $90.0M Series C round in Apr 2025. Investors include Frazier Life Sciences, Deep Track Capital and Goldman Sachs Alternatives.